# Erythromycin Versus Azithromycin in Preterm Premature Rupture of Membranes

> **NCT01556334** · PHASE3 · WITHDRAWN · sponsor: **Indiana University**

## Conditions studied

- Preterm Premature Ruptured Membranes

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Erythromycin

## Key facts

- **NCT ID:** NCT01556334
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-04
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Terminated before starting due to need for IND determined by FDA.
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01556334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01556334, "Erythromycin Versus Azithromycin in Preterm Premature Rupture of Membranes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01556334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*